Evidence map›Paper›PMID 29866255›Full record

ArticleeLife2018

The intractable challenge of evaluating cattle vaccination as a control for bovine Tuberculosis.

Andrew James Kerr Conlan, Martin Vordermeier, Mart Cm de Jong, James Ln Wood

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Bovine tuberculosis reactor cattle in Southwest Ethiopia: Risk factors for bovine tuberculosis.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  4. Article
  5. Vaccination of Calves with theAnimals : an open access journal from MDPI · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Andrew James Kerr ConlanDisease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2593-6353
Martin VordermeierDepartment of Bacteriology, Animal and Plant Health Agency, Weybridge, United Kingdom.
Mart Cm de JongQuantitative Veterinary Epidemiology, Wageningen University, Wageningen, Netherlands.ORCID 0000-0002-5339-1995
James Ln WoodDisease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-0258-3188
University of Cambridge · GBAnimal and Plant Health Agency · GBWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination of cattle against bovine Tuberculosis (bTB) has been a long-term policy objective for countries where disease continues to persist despite costly test-and-slaughter programs. The potential use of vaccination within the European Union has been linked to a need for field evaluation of any prospective vaccine and the impact of vaccination on the rate of transmission of bTB. We calculate that estimation of the direct protection of BCG could be achieved with 100 herds, but over 500 herds would be necessary to demonstrate an economic benefit for farmers whose costs are dominated by testing and associated herd restrictions. However, the low and variable attack rate in GB herds means field trials are unlikely to be able to discern any impact of vaccination on transmission. In contrast, experimental natural transmission studies could provide robust evaluation of both the efficacy and mode of action of vaccination using as few as 200 animals.

Indexed as

AnimalsCattleCommunicable Disease ControlMycobacterium bovisTuberculosis, BovineVaccinationBovine Tuberculosiscattlecomputational biologydisease dynamicsepidemiologyglobal healthmathematical modellingsystems biologytrial designvaccination

Identifiers

PMID29866255
PMCPMC5988428
OpenAlexW2806155434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.